NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma

Bibliography

• Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc 2014;11:404-6
   PubMedGoogle Scholar
• Usmani OS, Barnes PJ. Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease. Ann Med 2012;44:146-56
   PubMed Web of Science ®Google Scholar
• Yanai M, Sekizawa K, Ohrui T, et al. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992;72:1016-23
   PubMed Web of Science ®Google Scholar
• Bjermer L. History and future perspectives of treating asthma as a systemic and small airways disease. Respir Med 2001;95:703-19
   PubMed Web of Science ®Google Scholar
• Macklem PT. The physiology of small airways. Am J Respir Crit Care Med 1998;157:S181-3
   PubMed Web of Science ®Google Scholar
• Takeda T, Oga T, Niimi A, et al. Relationship between small airway function and health status, dyspnea and disease control in asthma. Respiration 2010;80:120-6
   PubMed Web of Science ®Google Scholar
• Kaminsky DA, Irvin CG, Gurka DA, et al. Peripheral airways responsiveness to cool, dry air in normal and asthmatic individuals. Am J Respir Crit Care Med 1995;152:1784-90
   PubMed Web of Science ®Google Scholar
• Kraft M, Djukanovic R, Torvik J, et al. Evaluation of airway inflammation by endobronchial and transbronchial biopsy in nocturnal and nonnocturnal asthma. Chest 1995;107:162S
   PubMed Web of Science ®Google Scholar
• Anderson WJ, Zajda E, Lipworth BJ. Are we overlooking persistent small airways. dysfunction in community-managed asthma? Ann Allergy Asthma Immunol 2012;109(3):185-9
   PubMed Web of Science ®Google Scholar
• Perez T, Chanez P, Dusser D, et al. Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction. Respir Med 2013;107:1667-74
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Niimi A, Ueda T, et al. Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. Pulm Pharmacol Ther 2009;22:326-32
   PubMed Web of Science ®Google Scholar
• Farah CS, King GG, Brown NJ, et al. The role of the small airways in the clinical expression of asthma in adults. J Allergy Clin Immunol 2012;129:381-7
   PubMed Web of Science ®Google Scholar
• Newman S. Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery. Expert Opin Drug Deliv 2014;11(3):365-78
   PubMed Web of Science ®Google Scholar
• Hesselink AE, Penninx BW, Wijnhoven HA, et al. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scan J Prim Health Care 2001;19:255-60
   PubMed Web of Science ®Google Scholar
• Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986;41:118-24
   PubMed Web of Science ®Google Scholar
• Goren A, Noviski N, Avital A, et al. Assessment of the ability of young children to use a powder inhaler device (Turbuhaler). Pediatr Pulmonol 1994;18:77-80
   PubMed Web of Science ®Google Scholar
• Bryant L, Bang C, Chew C, et al. Adequacy of inhaler technique used by people with asthma or chronic obstructive pulmonary disease. J Prim Health Care 2013;5:191-8
   PubMedGoogle Scholar
• Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005;50:1360-74
   PubMedGoogle Scholar
• Ninane V, Brusselle GG, Louis R, et al. Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement. Expert Opin Drug Deliv 2014;11:313-23
   PubMed Web of Science ®Google Scholar
• Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011;105:930-8
   PubMed Web of Science ®Google Scholar
• Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Am J Respir Crit Care Med 2005;172:1497-504
   PubMed Web of Science ®Google Scholar
• Leach CL, Kuehl PJ, Chand R, et al. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients. Ann Allergy Asthma Immunol 2012;108:195-200
   PubMed Web of Science ®Google Scholar
• Hirst PH, Bacon RE, Pitcairn GR, et al. A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients. Respir Med 2001;95:720-7
   PubMed Web of Science ®Google Scholar
• Paggiaro P, Nicolini G, Papi A. Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthma. Expert Rev Respir Med 2008;2:161-6
   PubMedGoogle Scholar
• Scichilone N, Spatafora M, Battaglia S, et al. Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations. J Asthma Allergy 2013;6:11-21
   PubMedGoogle Scholar
• Dekhuijzen PN, Vincken W, Virchow JC, et al. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med 2013;107:1817-21
   PubMed Web of Science ®Google Scholar
• Laube BL, Janssens HM, de Jongh FH, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011;37:1308-31
   PubMed Web of Science ®Google Scholar
• Newhouse MT, Nantel NP, Chambers CB, et al. Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates. Chest 1995;115:952-6
   Google Scholar
• Pasquali I, Brambilla G, Long E, et al. A visualization study for the aerosol generation in NEXThaler®. Poster presentation at the 2012 AAPS Annual Meeting and Exposition, October 14-18; 2012; Chicago, Poster: M1150
   Google Scholar
• Mariotti F, Sergio F, Acerbi D, et al. Lung deposition of the extra-fine dry powder fixed combination beclomethasone dipropionate plus formoterol fumarate via the NEXT DPI® in healthy subjects, asthmatic and COPD patients. Presented at the European Respiratory Society 21st Annual Congress; 24 – 28 September 2011; Amsterdam, The Netherlands
   Google Scholar
• Mitchell JP, Nagel MW. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. J Aerosol Med 2003;16:341-77
   PubMedGoogle Scholar
• De Backer W, Devolder A, Poli G, et al. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv 2010;23:137-48
   PubMed Web of Science ®Google Scholar
• Sergio F, Francisco C, Muraro A, et al. Beclometasone/formoterol administered via extrafine dry powder inhaler in controlled asthmatic patients: comparison with pMDI and beclometasone monotherapy. Presented at the European Respiratory Society 22st Annual Congress; 1 – 5 September 2012; Vienna, Austria
   Google Scholar
• Zuccaro F, Sergio F, Petruzzelli S, et al. Therapeutic equivalence of beclomethasone dipropionate/formoterol administered via NEXTTM DPI with beclomethasone dipropionate/formoterol administered via HFA pMDI in adult asthmatic patients. Presented at the European Respiratory Society 20th Annual Congress 18-22 September 2010; Barcelona, Spain. Eur Respir J 2010;36(Suppl 54):829s
   Google Scholar
• Scuri M, Alfieri V, Giorgio A, et al. Measurement of the inhalation profile through a novel dry powder inhaler (NEXThaler) in asthmatic patients using acoustic monitoring. Am J Respir Crit Care Med 2013;187:A1931
   Web of Science ®Google Scholar
• EMEA/CHMP/QWP/49313/2005corr. (2005): Committee For Medicinal Products For Human Use (CHMP). Guideline on the pharmaceutical quality of inhalation and nasal products
   Google Scholar
• Price D, Thomas M, Mitchell G, Niziol C. Improvement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated device. Respir Med 2003;97:12-19
   PubMed Web of Science ®Google Scholar
• Voshaar T, Spinola M, Linnane P, et al. Comparing usability of NEXThaler with other inhaled corticosteroid/long-acting beta2-agonist fixed combination dry powder inhalers in asthma patients. J Aerosol Med Pulm Drug Deliv 2013; doi: 10.1089/jamp.2013.1086
   PubMed Web of Science ®Google Scholar
• Anderson P. Patient preference for and satisfaction of inhaler devices. Eur Respir Rev 2005;14:109-16
   Google Scholar